IXICO plc
PHYOF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | – | $3,208 | $3,228 | $2,538 |
| % Growth | – | -0.6% | 27.2% | – |
| Cost of Goods Sold | – | $1,618 | $1,667 | $1,518 |
| Gross Profit | – | $1,590 | $1,561 | $1,020 |
| % Margin | – | 49.6% | 48.4% | 40.2% |
| R&D Expenses | – | $626 | $714 | $623 |
| G&A Expenses | – | $1,318 | $0 | $1,454 |
| SG&A Expenses | – | $2,180 | $1,938 | $2,241 |
| Sales & Mktg Exp. | – | $862 | $0 | $787 |
| Other Operating Expenses | – | -$287 | $0 | -$256 |
| Operating Expenses | – | $2,519 | $2,652 | $2,608 |
| Operating Income | – | -$929 | -$1,091 | -$1,588 |
| % Margin | – | -29% | -33.8% | -62.6% |
| Other Income/Exp. Net | – | $40 | $541 | $44 |
| Pre-Tax Income | – | -$889 | -$550 | -$1,544 |
| Tax Expense | – | $69 | $38 | -$131 |
| Net Income | – | -$958 | -$588 | -$1,413 |
| % Margin | – | -29.9% | -18.2% | -55.7% |
| EPS | – | -0.011 | -0.012 | -0.029 |
| % Growth | – | 9% | 58.2% | – |
| EPS Diluted | – | -0.011 | -0.012 | -0.029 |
| Weighted Avg Shares Out | – | 86,229 | 48,351 | 48,352 |
| Weighted Avg Shares Out Dil | – | 86,226 | 48,351 | 48,351 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $47 | $30 | $55 |
| Interest Expense | – | $7 | $14 | $11 |
| Depreciation & Amortization | – | $208 | $234 | $241 |
| EBITDA | – | -$721 | -$302 | -$1,347 |
| % Margin | – | -22.5% | -9.4% | -53.1% |